Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term:amphetamine abuse
go back to main search page
Accession:DOID:670 term browser browse the term
Definition:A substance abuse that involves the recurring use of amphetamines despite negative consequences. (DO)
Synonyms:exact_synonym: amphetamine use disorder;   amphetamine-related disorder;   amphetamine-related disorders
 narrow_synonym: Amphetamine Addiction;   Amphetamine Dependence;   METHAMPHETAMINE USE DISORDER;   methamphetamine dependence
 primary_id: MESH:D019969
 xref: EFO:0004701;   ICD9CM:305.7
For additional species annotation, visit the Alliance of Genome Resources.


show annotations for term's descendants           Sort by:
amphetamine abuse term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16470869 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410 		JBrowse link
G Acsl6 acyl-CoA synthetase long-chain family member 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr10:38,940,668...38,999,515
Ensembl chr10:38,940,747...39,002,873 		JBrowse link
G Adora2a adenosine A2a receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:20799992 NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802 		JBrowse link
G Ak5 adenylate kinase 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 2:244,057,240...244,241,372
Ensembl chr 2:244,057,240...244,241,366 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 no_association
susceptibility 		ISO CTD Direct Evidence: marker/mechanism
DNA:SNPs:introns: (rs2494743, 2498794)
DNA:SNP:intron: (rs3730358) 		CTD
RGD		 PMID:15982448 PMID:31654273 PMID:15982448 RGD:407419880, RGD:407419878 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Aoah acyloxyacyl hydrolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr17:48,503,812...48,745,161
Ensembl chr17:48,503,812...48,745,146 		JBrowse link
G Arc activity-regulated cytoskeleton-associated protein disease_progression ISO mRNA:increased expression:brain (mouse) RGD PMID:25959066 RGD:401938592 NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220 		JBrowse link
G Arrb2 arrestin, beta 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17233643 NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,645,357...55,653,487 		JBrowse link
G Astn2 astrotactin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 5:83,772,988...84,759,439
Ensembl chr 5:83,773,633...84,759,485 		JBrowse link
G Bdnf brain-derived neurotrophic factor ISO
IEP 		CTD Direct Evidence: marker/mechanism
protein:increased expression:frontal cortex, striatum
protein:increased expression:nucleus accumbens, ventral tegmental area
mRNA:increased expression:nucleus accumbens, dorsal striatum
protein:decreased expression:hippocampus 		CTD
RGD		 PMID:20736000 PMID:31693929 PMID:37904065 PMID:33961872 PMID:24407463 RGD:597015747, RGD:596938173, RGD:596936246, RGD:401976437 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Cartpt CART prepropeptide IEP mRNA:increased expression:striatum RGD PMID:28827541 RGD:407984842 NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:32,989,215...32,999,712 		JBrowse link
G Cat catalase treatment IEP RGD PMID:24445072 RGD:405255657 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cchcr1 coiled-coil alpha-helical rod protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr20:3,210,383...3,223,187
Ensembl chr20:3,210,384...3,222,765 		JBrowse link
G Cd4 Cd4 molecule IEP protein:decreased expression:spleen (rat) RGD PMID:25678251 RGD:407446373 NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:159,356,337...159,381,461 		JBrowse link
G Cd55 CD55 molecule (Cromer blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107 		JBrowse link
G Cd8a CD8 subunit alpha IEP protein:increased expression:spleen (rat) RGD PMID:25678251 RGD:407446373 NCBI chr 4:104,924,116...104,928,353
Ensembl chr 4:104,900,833...104,928,358 		JBrowse link
G Cdh13 cadherin 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119 		JBrowse link
G Cdk5 cyclin-dependent kinase 5 ISO protein:increased expression:ventral tegmental area, nucleus accumbens (mouse) RGD PMID:28782589 RGD:401900303 NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777 		JBrowse link
G Cfh complement factor H ISO
IEP 		protein:increased expression:serum:
protein:increased expression:serum, hippocampus: 		RGD PMID:22871478 PMID:22871478 RGD:7364944, RGD:7364944 NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532 		JBrowse link
G Col28a1 collagen type XXVIII alpha 1 chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 4:37,036,303...37,189,435
Ensembl chr 4:37,035,761...37,189,494 		JBrowse link
G Comt catechol-O-methyltransferase susceptibility ISO CTD Direct Evidence: marker/mechanism
DNA:SNP:cd: p.V158M (human)
DNA:SNPs,haplotypes:exon,3'utr: (rs4680, rs165599) (human)
ClinVar Annotator: match by term: methamphetamine use disorder 		CTD
ClinVar
RGD		 PMID:15274053 PMID:25741868 PMID:33544778 PMID:21934638 PMID:17187009 More... RGD:401959602, RGD:401940147, RGD:401940150, RGD:401940124 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 treatment ISO
IEP 		protein:increases activity:ventral tegmental area, nucleus accumbens (mouse)
mRNA:decreased expression:nucleus accumbens
protein:increased expression, increased phosphorylation:nucleus accumbens, ventral tegmental area 		RGD PMID:28782589 PMID:33961872 PMID:31900897 RGD:401900303, RGD:596936246, RGD:401938636 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Csmd1 CUB and Sushi multiple domains 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr16:78,920,549...80,520,710
Ensembl chr16:78,921,002...80,519,944 		JBrowse link
G Cubn cubilin ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr17:81,293,619...81,501,694
Ensembl chr17:81,293,619...81,501,694 		JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18280655 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837 		JBrowse link
G Dcstamp dendrocyte expressed seven transmembrane protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 7:72,692,364...72,706,983
Ensembl chr 7:72,671,477...72,707,009 		JBrowse link
G Drd1 dopamine receptor D1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18363855 PMID:19444617 NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166 		JBrowse link
G Drd2 dopamine receptor D2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18363855 PMID:18555060 PMID:19940168 NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339 		JBrowse link
G Drd3 dopamine receptor D3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19940168 NCBI chr11:70,385,586...70,437,793
Ensembl chr11:70,385,586...70,446,760 		JBrowse link
G Drd4 dopamine receptor D4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15274053 NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:205,826,049...205,830,458 		JBrowse link
G Ephx1 epoxide hydrolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19598248 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Fhit fragile histidine triad diadenosine triphosphatase ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr15:16,365,401...17,872,901
Ensembl chr15:16,747,338...17,872,621 		JBrowse link
G Fkbp15 FKBP prolyl isomerase family member 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 5:80,766,356...80,830,622
Ensembl chr 5:80,766,356...80,830,565 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit ISO
IEP 		CTD Direct Evidence: marker/mechanism
protein:increased expression:nucleus accumbens,striatum
mRNA:increased expression:nucleus accumbens 		CTD
RGD		 PMID:19689456 PMID:18834549 PMID:24183790 RGD:405255667, RGD:405100720 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Fosb FosB proto-oncogene, AP-1 transcription factor subunit ISO
IEP 		protein:increased expression:ventral tegmental area, nucleus accumbens (mouse)
associated with stress related disorder;protein:increased expression:brain (rat) 		RGD PMID:28782589 PMID:27672362 PMID:31373119 RGD:401900303, RGD:401901183, RGD:401900735 NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:88,082,127...88,089,477 		JBrowse link
G Gabbr1 gamma-aminobutyric acid type B receptor subunit 1 susceptibility ISO DNA:SNPs, halotypes:intron (rs2076483,rs29221,rs715044) (human) RGD PMID:30143926 RGD:401940101 NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,469,779...1,498,607 		JBrowse link
G Gabrg2 gamma-aminobutyric acid type A receptor subunit gamma 2 sexual_dimorphism ISO CTD Direct Evidence: marker/mechanism
DNA:missense mutation:exon 8:p.K289M (rs4480617) (human) 		CTD
RGD		 PMID:15772696 PMID:14569258 RGD:402528887 NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523 		JBrowse link
G Gad1 glutamate decarboxylase 1 susceptibility ISO DNA:haplotype: :rs769404���rs701492(human) RGD PMID:27967329 RGD:401900122 NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759 		JBrowse link
G Gad2 glutamate decarboxylase 2 susceptibility ISO DNA:SNP: :rs2236418(human) RGD PMID:27967329 RGD:401900122 NCBI chr17:89,671,718...89,734,246
Ensembl chr17:89,671,716...89,941,089 		JBrowse link
G Gdnf glial cell derived neurotrophic factor treatment ISO
IEP 		CTD Direct Evidence: marker/mechanism
protein:increased expression:nucleus accumbens, ventral tegmental area 		CTD
RGD		 PMID:17356005 PMID:37904065 PMID:23432945 RGD:596938173, RGD:405850210 NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240 		JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 IEP methamphetamine abuse;protein:increased expression:hippocampal formation, striatum, prefrontal cortex (rat) RGD PMID:37778205 RGD:405100237 NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309 		JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 IMP RGD PMID:16311338 RGD:596933067 NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616 		JBrowse link
G Grm2 glutamate metabotropic receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20211215 NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:116,158,810...116,171,857 		JBrowse link
G Grm5 glutamate metabotropic receptor 5 ameliorates IMP RGD PMID:18991866 RGD:598099550 NCBI chr 1:150,722,711...151,297,585
Ensembl chr 1:150,733,678...151,296,649 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19254865 NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15729709 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18186040 PMID:19254865 NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019 		JBrowse link
G Hdac8 histone deacetylase 8 IEP mRNA:decreased expression:striatum (rat) RGD PMID:25452209 RGD:9681719 NCBI chr  X:71,425,240...71,632,865
Ensembl chr  X:71,394,928...71,632,865 		JBrowse link
G Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 1:187,970,127...188,375,869
Ensembl chr 1:187,969,943...188,375,465 		JBrowse link
G Htr1b 5-hydroxytryptamine receptor 1B ISO CTD Direct Evidence: therapeutic CTD PMID:10780831 NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583 		JBrowse link
G Htr3a 5-hydroxytryptamine receptor 3A ISO CTD Direct Evidence: marker/mechanism CTD PMID:19689456 NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:58,138,226...58,150,884 		JBrowse link
G Htr6 5-hydroxytryptamine receptor 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20705401 NCBI chr 5:156,579,901...156,595,147
Ensembl chr 5:156,579,901...156,595,147 		JBrowse link
G Il6 interleukin 6 IEP mRNA:increased expression:ventral tegmental area RGD PMID:31282647 RGD:598092520 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Large1 LARGE xylosyl- and glucuronyltransferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr19:11,609,004...12,057,174
Ensembl chr19:11,609,004...12,054,707 		JBrowse link
G Lingo2 leucine rich repeat and Ig domain containing 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 5:55,166,250...56,488,672
Ensembl chr 5:55,156,997...56,489,155 		JBrowse link
G Map2k5 mitogen activated protein kinase kinase 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 8:72,520,616...72,748,395
Ensembl chr 8:72,520,617...72,747,373 		JBrowse link
G Mb myoglobin ISO RGD PMID:12935649 RGD:458925289 NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:110,640,512...110,647,958 		JBrowse link
G Mtarc1 mitochondrial amidoxime reducing component 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr13:98,854,235...98,894,208
Ensembl chr13:98,871,289...98,894,252 		JBrowse link
G Mtarc2 mitochondrial amidoxime reducing component 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr13:98,894,347...98,928,754
Ensembl chr13:98,897,108...98,928,781 		JBrowse link
G Myo5b myosin Vb ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr18:70,313,717...70,613,918
Ensembl chr18:70,311,990...70,613,918 		JBrowse link
G Nos1 nitric oxide synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15542708 NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837 		JBrowse link
G Npy1r neuropeptide Y receptor Y1 ISO CTD Direct Evidence: marker/mechanism
DNA:SNP:intron: (rs7687423) (human) 		CTD
RGD		 PMID:19566775 PMID:19566775 RGD:402463941 NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387 		JBrowse link
G Nrg1 neuregulin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849 		JBrowse link
G Ntrk2 neurotrophic receptor tyrosine kinase 2 IEP
ISO 		mRNA:increased expression:nucleus accumbens
protein:increased expression:frontal cortex, striatum
protein:altered expression:nucleus accumbens, ventral tegmental area 		RGD PMID:33961872 PMID:31693929 PMID:37904065 PMID:34273388 RGD:596936246, RGD:597015747, RGD:596938173, RGD:596938171 NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628 		JBrowse link
G Oprm1 opioid receptor, mu 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16402083 NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:45,565,371...45,638,756 		JBrowse link
G Oxt oxytocin/neurophysin I prepropeptide IEP mRNA:increased expression:nucleus accumbens RGD PMID:28827541 RGD:407984842 NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:138,235,754...138,236,594 		JBrowse link
G Pcolce2 procollagen C-endopeptidase enhancer 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 8:105,073,086...105,130,725
Ensembl chr 8:105,073,086...105,145,160 		JBrowse link
G Pde4b phosphodiesterase 4B ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:122,135,174...122,598,267 		JBrowse link
G Pde4d phosphodiesterase 4D ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:42,110,838...43,262,569 		JBrowse link
G Pde6c phosphodiesterase 6C ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 1:245,322,015...245,377,874
Ensembl chr 1:245,322,015...245,377,852 		JBrowse link
G Pdyn prodynorphin ISO
IEP 		CTD Direct Evidence: marker/mechanism
mRNA:increased expression:nucleus acccumbens
mRNA:increased expression:nucleus accumbens
mRNA:increased expression:central amygdaloid nucleus
mRNA:altered expression:brain
DNA:repeat:promoter:rs35286251 (human) 		CTD
RGD		 PMID:16529859 PMID:27989838 PMID:22390687 PMID:12523490 PMID:16289352 More... RGD:401851910, RGD:401851043, RGD:401850585, RGD:401850564, RGD:401850552 NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:137,354,161...137,366,503 		JBrowse link
G Pick1 protein interacting with PRKCA 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17606663 NCBI chr 7:112,676,890...112,697,275
Ensembl chr 7:112,677,322...112,697,257 		JBrowse link
G Plat plasminogen activator, tissue type ISO CTD Direct Evidence: marker/mechanism CTD PMID:15659235 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Pou5f1 POU class 5 homeobox 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,227,837...3,232,598 		JBrowse link
G Prdm2 PR/SET domain 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 5:160,704,396...160,815,184
Ensembl chr 5:160,705,462...160,815,140 		JBrowse link
G Prkaca protein kinase cAMP-activated catalytic subunit alpha treatment IEP protein:increased expression, increased phosphorylation:nucleus accumbens, ventral tegmental area RGD PMID:31900897 RGD:401938636 NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494 		JBrowse link
G Prkg1 protein kinase cGMP-dependent 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 1:237,818,950...239,052,184
Ensembl chr 1:237,823,053...239,103,005 		JBrowse link
G Prokr2 prokineticin receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20576534 NCBI chr 3:140,077,629...140,092,327
Ensembl chr 3:140,077,630...140,092,093 		JBrowse link
G Psd3 pleckstrin and Sec7 domain containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr16:26,238,595...26,802,535
Ensembl chr16:26,340,028...26,802,535 		JBrowse link
G Raly RALY heterogeneous nuclear ribonucleoprotein ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 3:163,766,183...163,830,726
Ensembl chr 3:163,766,478...163,830,740 		JBrowse link
G Rapgef5 Rap guanine nucleotide exchange factor 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 6:144,588,162...144,822,908
Ensembl chr 6:144,580,976...144,822,908 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:19689456 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Rgs17 regulator of G-protein signaling 17 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 1:44,627,583...44,729,957
Ensembl chr 1:44,632,964...44,729,945 		JBrowse link
G Serpina5 serpin family A member 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 6:128,774,006...128,793,187
Ensembl chr 6:128,784,991...128,793,186 		JBrowse link
G Sgcz sarcoglycan zeta ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr16:60,363,718...61,444,256
Ensembl chr16:60,363,738...61,439,633 		JBrowse link
G Sh3rf3 SH3 domain containing ring finger 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr20:27,306,937...27,642,315
Ensembl chr20:27,308,188...27,640,544 		JBrowse link
G Slc6a3 solute carrier family 6 member 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12931138 NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962 		JBrowse link
G Slc6a4 solute carrier family 6 member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19689456 NCBI chr10:62,322,688...62,357,060
Ensembl chr10:62,324,254...62,357,056 		JBrowse link
G Slc6a9 solute carrier family 6 member 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17582620 NCBI chr 5:136,660,022...136,694,173
Ensembl chr 5:136,659,948...136,694,172 		JBrowse link
G Smyd3 SET and MYND domain containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr13:93,241,274...93,798,221
Ensembl chr13:93,241,279...93,798,237 		JBrowse link
G Snca synuclein alpha treatment IMP
ISO 		CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:15542733 PMID:32278788 PMID:20551914 RGD:13506280 NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:91,026,474...91,126,315 		JBrowse link
G Tph2 tryptophan hydroxylase 2 ISO protein:decreased expression:hippocampus RGD PMID:26747301 RGD:597805906 NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:52,571,911...52,675,639 		JBrowse link
G Trpm3 transient receptor potential cation channel, subfamily M, member 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 1:229,099,741...229,984,172
Ensembl chr 1:229,099,542...229,984,172 		JBrowse link
G Trpv1 transient receptor potential cation channel, subfamily V, member 1 ISO mRNA:increased expression:frontal cortex RGD PMID:20122992 RGD:598130087 NCBI chr10:58,349,936...58,375,021
Ensembl chr10:58,340,223...58,375,021 		JBrowse link
G Usp48 ubiquitin specific peptidase 48 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr 5:155,083,520...155,151,208
Ensembl chr 5:155,083,587...155,151,208 		JBrowse link
G Zfp385d zinc finger protein 385D ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr15:7,473,431...7,854,364
Ensembl chr15:7,473,435...8,504,582 		JBrowse link
G Zfp423 zinc finger protein 423 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18316681 NCBI chr19:35,282,149...35,580,775
Ensembl chr19:35,282,110...35,580,773 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  disease 19167
    Chemically-Induced Disorders 1510
      substance-related disorder 850
        substance abuse 315
          amphetamine abuse 97
Path 2
Term Annotations click to browse term
  disease 19167
    disease of anatomical entity 18473
      nervous system disease 14369
        central nervous system disease 12646
          brain disease 11866
            disease of mental health 8496
              substance-related disorder 850
                substance abuse 315
                  amphetamine abuse 97
paths to the root